5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Unique morphologic characteristics of high grade urothelial carcinoma with fibroblast growth factor receptor-3 (FGFR3) gene mutations
    Meeting Abstract

    Al-Ahmadie, H. A.; Liu, O.; Tyer, G. V.; Heguy, A.; Gopalan, A.; Fine, S. W.; Tiekoo, S. K.; Hanrahan, A. J.; Bajorin, D. F.; Reuter, V. E.; more...
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate
    Journal Article

    Reid, A. H. M.; Attard, G.; Danila, D. C.; Oommen, N. B.; Olmos, D.; Fong, P. C.; Molife, L. R.; Hunt, J.; Messiou, C.; Parker, C.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer
    Journal Article

    Reidy, D. L.; Vakiani, E.; Fakih, M. G.; Saif, M. W.; Hecht, J. R.; Goodman-Davis, N.; Hollywood, E.; Shia, J. R.; Schwartz, J.; Chandrawansa, K.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer
    Journal Article

    Rathkopf, D.; Wong, B. Y.; Ross, R. W.; Anand, A.; Tanaka, E.; Woo, M. M.; Hu, J.; Dzik-Jurasz, A.; Yang, W.; Scher, H. I.
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors
    Journal Article

    Lockhart, A. C.; Rothenberg, M. L.; Dupont, J.; Cooper, W.; Chevalier, P.; Sternas, L.; Buzenet, G.; Koehler, E.; Sosman, J. A.; Schwartz, L. H.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Acquired KRAS mutation as mechanism of resistance to EGFR inhibition in colorectal cancer
    Meeting Abstract

    Liska, D.; Janakiraman, M.; Chen, C. T.; Ding, P. R. ; Solit, D. B.; Weiser, M. R.
    Journal of the American College of Surgeons (2010)

    Fulltext@MSK | Save
  • Correlation of selected somatic mutations and pathologic stage in high grade urothelial carcinomas
    Meeting Abstract

    Lin, O.; Solit, D.; Al-Ahmadie, H.; Heguy, A.; Reuter, V. E.; Ishill, N. M.; Milowsky, M.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Clinical implications of selected somatic mutations in the recurrence of invasive urothelial carcinomas
    Meeting Abstract

    Lin, O.; Solit, D.; Al-Ahmadie, H.; Heguy, A.; Reuter, V. E.; Ishill, N.; Milowksy, M.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Frequency of somatic mutations in high grade urothelial carcinomas
    Meeting Abstract

    Lin, O.; Solit, D.; Al-Ahmadie, H.; Heguy, A.; Ishill, N.; Reuter, V. E.; Milowsky, M.
    Laboratory Investigation (2010)

    Fulltext@MSK | Save
  • Phase II study of sunitinib in patients with metastatic urothelial cancer
    Journal Article

    Gallagher, D. J.; Milowsky, M. I.; Gerst, S. R.; Ishill, N.; Riches, J.; Regazzi, A.; Boyle, M. G.; Trout, A.; Flaherty, A. M.; Bajorin, D. F.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save